These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

820 related items for PubMed ID: 28772160

  • 1. Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents.
    Abdelgawad MA, Bakr RB, Omar HA.
    Bioorg Chem; 2017 Oct; 74():82-90. PubMed ID: 28772160
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors.
    Paramashivappa R, Phani Kumar P, Subba Rao PV, Srinivasa Rao A.
    Bioorg Med Chem Lett; 2003 Feb 24; 13(4):657-60. PubMed ID: 12639552
    [Abstract] [Full Text] [Related]

  • 6. Novel benzothiazole, benzimidazole and benzoxazole derivatives as potential antitumor agents: synthesis and preliminary in vitro biological evaluation.
    Xiang P, Zhou T, Wang L, Sun CY, Hu J, Zhao YL, Yang L.
    Molecules; 2012 Jan 17; 17(1):873-83. PubMed ID: 22252503
    [Abstract] [Full Text] [Related]

  • 7. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study.
    Abdelgawad MA, Labib MB, Abdel-Latif M.
    Bioorg Chem; 2017 Oct 17; 74():212-220. PubMed ID: 28865292
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase.
    Yuan X, Yang Q, Liu T, Li K, Liu Y, Zhu C, Zhang Z, Li L, Zhang C, Xie M, Lin J, Zhang J, Jin Y.
    Eur J Med Chem; 2019 Oct 01; 179():147-165. PubMed ID: 31252306
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and Anticancer Activity of Benzimidazole/Benzoxazole Substituted Triazolotriazines in Hepatocellular Carcinoma.
    Dadashpour S, Küçükkılınç TT, Ercan A, Hosseinimehr SJ, Naderi N, Irannejad H.
    Anticancer Agents Med Chem; 2019 Oct 01; 19(17):2120-2129. PubMed ID: 31393257
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents.
    Reddy TS, Kulhari H, Reddy VG, Bansal V, Kamal A, Shukla R.
    Eur J Med Chem; 2015 Aug 28; 101():790-805. PubMed ID: 26231080
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA, Abdel-Mohsen HT, El Kerdawy AM, Ragab FAF, Ali MM, Abu-Bakr SM, Girgis AS, El Diwani HI.
    Eur J Med Chem; 2017 Aug 18; 136():315-329. PubMed ID: 28505536
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and in vitro antiproliferative evaluation of some B-norcholesteryl Benzimidazole and Benzothiazole derivatives.
    Cui J, Qi B, Gan C, Liu Z, Huang H, Lin Q, Zhao D, Huang Y.
    Mar Drugs; 2015 Apr 22; 13(4):2488-504. PubMed ID: 25913705
    [Abstract] [Full Text] [Related]

  • 14. Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.
    Cindrić M, Jambon S, Harej A, Depauw S, David-Cordonnier MH, Kraljević Pavelić S, Karminski-Zamola G, Hranjec M.
    Eur J Med Chem; 2017 Aug 18; 136():468-479. PubMed ID: 28525845
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors.
    Akhtar MJ, Khan AA, Ali Z, Dewangan RP, Rafi M, Hassan MQ, Akhtar MS, Siddiqui AA, Partap S, Pasha S, Yar MS.
    Bioorg Chem; 2018 Aug 18; 78():158-169. PubMed ID: 29571113
    [Abstract] [Full Text] [Related]

  • 16. 1,3,4-Trisubstituted pyrazole analogues as promising anti-inflammatory agents.
    Alegaon SG, Alagawadi KR, Garg MK, Dushyant K, Vinod D.
    Bioorg Chem; 2014 Jun 18; 54():51-9. PubMed ID: 24793214
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
    A A Fadaly W, A M M Elshaier Y, T M Nemr M, R A Abdellatif K.
    Bioorg Chem; 2023 May 18; 134():106428. PubMed ID: 36893546
    [Abstract] [Full Text] [Related]

  • 18. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA, Elshaier YAMM, Hassanein EHM, Abdellatif KRA.
    Bioorg Chem; 2020 May 18; 98():103752. PubMed ID: 32197148
    [Abstract] [Full Text] [Related]

  • 19. Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids, and molecular modeling.
    Hawash M, Abdallah S, Abudayyak M, Melhem Y, Abu Shamat M, Aghbar M, Çapan I, Abualhasan M, Kumar A, Kamiński M, Góral T, Dominiak PM, Sobuh S.
    Eur J Med Chem; 2024 May 05; 271():116397. PubMed ID: 38626522
    [Abstract] [Full Text] [Related]

  • 20. Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition.
    Ren SZ, Wang ZC, Zhu XH, Zhu D, Li Z, Shen FQ, Duan YT, Cao H, Zhao J, Zhu HL.
    Bioorg Med Chem; 2018 Aug 07; 26(14):4264-4275. PubMed ID: 30031652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.